N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide
C107H120F12N22O12 — CID 157088496
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide
N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide (PubChem CID 157088496) has the molecular formula C107H120F12N22O12 and a molecular weight of 2134.25 g/mol. Its IUPAC name is N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide.
Molecular Properties
| Compound Name | N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide |
|---|---|
| PubChem CID | 157088496 |
| Molecular Formula | C107H120F12N22O12 |
| Molecular Weight | 2134.25 g/mol |
| Exact Mass | 2132.93 |
| IUPAC Name | N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(1-hydroxycyclobutyl)acetamide;(2R)-N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;(2S)-2,3-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]butanamide;(1S)-2,2-dimethyl-N-[6-methyl-1-(3-methyl-1,2-oxazol-5-yl)benzimidazol-2-yl]cyclopropane-1-carboxamide;3,3-dimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide;(2S)-2,3,3-trimethyl-N-[1-(3-methyl-1,2-oxazol-5-yl)-6-(trifluoromethyl)benzimidazol-2-yl]butanamide |
| SMILES | C[C@@](O)(C(=O)Nc1nc2ccc(C(F)(F)F)cc2n1C1CCC1)C(F)(F)F.Cc1cc(-n2c(NC(=O)CC(C)(C)C)nc3ccc(C(F)(F)F)cc32)on1.Cc1cc(-n2c(NC(=O)[C@@H](C)C(C)(C)C)nc3ccc(C(F)(F)F)cc32)on1.Cc1ccc2nc(NC(=O)CC3(O)CCC3)n(C3CCC3)c2c1.Cc1ccc2nc(NC(=O)[C@@H](C)C(C)C)n(-c3cc(C)no3)c2c1.Cc1ccc2nc(NC(=O)[C@H]3CC3(C)C)n(-c3cc(C)no3)c2c1 |
| InChI | InChI=1S/C19H21F3N4O2.C18H19F3N4O2.C18H20N4O2.C18H22N4O2.C18H23N3O2.C16H15F6N3O2/c1-10-8-15(28-25-10)26-14-9-12(19(20,21)22)6-7-13(14)23-17(26)24-16(27)11(2)18(3,4)5;1-10-7-15(27-24-10)25-13-8-11(18(19,20)21)5-6-12(13)22-16(25)23-14(26)9-17(2,3)4;1-10-5-6-13-14(7-10)22(15-8-11(2)21-24-15)17(19-13)20-16(23)12-9-18(12,3)4;1-10(2)13(5)17(23)20-18-19-14-7-6-11(3)8-15(14)22(18)16-9-12(4)21-24-16;1-12-6-7-14-15(10-12)21(13-4-2-5-13)17(19-14)20-16(22)11-18(23)8-3-9-18;1-14(27,16(20,21)22)12(26)24-13-23-10-6-5-8(15(17,18)19)7-11(10)25(13)9-3-2-4-9/h6-9,11H,1-5H3,(H,23,24,27);5-8H,9H2,1-4H3,(H,22,23,26);5-8,12H,9H2,1-4H3,(H,19,20,23);6-10,13H,1-5H3,(H,19,20,23);6-7,10,13,23H,2-5,8-9,11H2,1H3,(H,19,20,22);5-7,9,27H,2-4H2,1H3,(H,23,24,26)/t11-;;12-;13-;;14-/m1.10.1/s1 |
| InChIKey | AEJKUHMBXTUBHX-WWWLKFFLSA-N |
| XLogP | 24.50 |
| TPSA | 426.10 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 153 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2134.25 |
| LogP ≤ 5 | 24.50 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 28 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157088496 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.